Enhancing genetic disease control by selecting for lower host infectivity and susceptibility | Heredity
Eliminated vs. Eradicated: Erasing disease from history — Atlantic Health Partners
Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics | Journal of the American Chemical Society
Vaccines | Free Full-Text | Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate
Spherical nucleic acids as an infectious disease vaccine platform | PNAS
Vaccination and immunotherapies in neuroimmunological diseases | Nature Reviews Neurology
Host genetics and infectious disease: new tools, insights and translational opportunities | Nature Reviews Genetics
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes | Science
Peptides for Vaccine Development | ACS Applied Bio Materials
A mass spectrometry guided approach for the identification of novel vaccine candidates in gram-negative pathogens | Scientific Reports
Disease Eradication: What Does It Take to Wipe out a Disease?
Live attenuated vaccines, a favorable strategy to provide long-term immunity against protozoan diseases: Trends in Parasitology
Frontiers | SARS-CoV-2 Variants, Vaccines, and Host Immunity
Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs | PLOS ONE
Next-generation T cell–activating vaccination increases influenza virus mutation prevalence | Science Advances
B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19 - eBioMedicine
Prospects for a safe COVID-19 vaccine | Science Translational Medicine
Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — United States, December 14, 2020–April 10, 2021 | MMWR
Animals | Free Full-Text | Transboundary Animal Diseases, an Overview of 17 Diseases with Potential for Global Spread and Serious Consequences
Vaccines | Free Full-Text | A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers | NEJM
Prevention of host-to-host transmission by SARS-CoV-2 vaccines - The Lancet Infectious Diseases
COVID-19 vaccine development: milestones, lessons and prospects | Signal Transduction and Targeted Therapy
Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case- control study and a mechanistic study of post-vaccination immune responses - The Lancet Infectious
